A new study from researchers at Wake Forest University School of Medicine shows that only 3.5 years of intensive blood ...

Intensive blood pressure control for adults with hypertension and high cardiovascular risk can reduce the risk of mild ...

Q. Two members of our book group have early signs of cognitive impairment. We have become so close after 10 years of being ...

"If you look at all the things we know that may be associated with the risk of developing dementia, the two strongest are age ...

The US Food and Drug Administration (FDA) has approved Eisai and Biogen’s Supplemental Biologics License Application for once ...

A new study by researchers at Wake Forest University School of Medicine shows that only 3.5 years of intensive blood pressure ...

Rates of both MCI and composite of MCI or probable dementia lower with intensive treatment in extended follow-up study ...

Published in the journal Neurology, the results showed that intensive blood pressure control for three and a half years ...

Tight control over blood pressure can protect brain health against aging. Seniors had reduced risk of mild cognitive ...

Biogen (BIIB) and Eisai announced an update on the ongoing regulatory review of the Marketing Authorization Application for lecanemab as ...

During the years of follow-up, 248 of those who had undergone intensive blood pressure treatment were determined to have probable dementia or mild cognitive impairment, compared with 293 ...